Siti Nurul Hidayah
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Siti Nurul Hidayah has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Hartmut Schlüter
Section Mass Spectrometry and Proteomics, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany
3 shared publications - Laura Heikaus
Mass Spectrometric Proteomics, Institute of Clinical Chemistry and Laboratory Medicine, Campus Forschung, N27 Raum 00.008, Universitätsklinikum Hamburg-Eppendorf, Martinistr. 52, 20246 Hamburg, Germany
3 shared publications - Manasi Gaikwad
Mass Spectrometric Proteomics, Institute of Clinical Chemistry and Laboratory Medicine, Campus Forschung, N27 Raum 00.008, Universitätsklinikum Hamburg-Eppendorf, Martinistr. 52, 20246 Hamburg, Germany
3 shared publications - Amirhossein Saadati
AryoGen Pharmed, Cross Tajbakhsh Street, 24th Kilometer Makhsous, Tehran, Iran
2 shared publications - Behrouz Vaziri
Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran
2 shared publications - Christoph Krisp
Institute of Clinical Chemistry and Laboratory Medicine, Mass Spectrometric Proteomics, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany
2 shared publications
Latest Publications
- Open Access
- 7 April 2026
- Published by Indonesian Society Fisheries Product Processing in Jurnal Pengolahan Hasil Perikanan Indonesia
- Vol. 29 (3) , 224-237
Physicochemical characterization and peptide profiling of gelatin from the invasive species Amphilophus labiatus
Bahan aktif berbasis protein dan peptida telah menjadi fokus utama dalam pengembangan farmasi dan kosmetik modern karena keunggulannya dalam biokompatibilitas, spesifisitas target, serta efektivitas pada dosis rendah. Kolagen ikan dan produk degradasinya, yaitu gelatin, merupakan kandidat menjanjikan untuk sumber biomolekul fungsional tersebut. Penelitian ini mengeksplorasi potensi kulit ikan setan merah (Amphilophus labiatus), spesies invasif yang melimpah di Indonesia sebagai sumber alternatif gelatin bernilai tambah. Gelatin diekstraksi dengan metode asam menggunakan 3 variasi konsentrasi asam asetat, yaitu 1, 2, dan 3% (0% sebagai kontrol) dan dikarakterisasi berdasarkan sifat fisikokimia (kekuatan gel dan viskositas) serta profil peptidanya. Perlakuan terbaik diperoleh pada perlakuan menggunakan asam asetat 3% yang menghasilkan rendemen 12,95% dengan kadar protein tinggi (87,2%), kekuatan gel 257,17±17,1 bloom, dan viskositas 6,84±0,87 cP. Analisis lanjutan menggunakan spektrometri massa tandem resolusi tinggi mengidentifikasi 20 jenis kolagen berbeda, dengan kolagen tipe I sebagai yang dominan, serta protein lain dengan domain mirip kolagen seperti kolagen IV NC1 dan fibrillar collagen NC1. Temuan ini menegaskan potensi kulit ikan red devil tidak hanya sebagai strategi pemanfaatan spesies invasif, tetapi juga sebagai sumber biomaterial inovatif untuk aplikasi farmasi dan kosmetik berbasis protein.
- 7 April 2026
- Published by Indonesian Society Fisheries Product Processing in Jurnal Pengolahan Hasil Perikanan Indonesia
- Vol. 29 (3) , 224-237
Open AccessPhysicochemical characterization and peptide profiling of gelatin from the invasive species Amphilophus labiatus
Bahan aktif berbasis protein dan peptida telah menjadi fokus utama dalam pengembangan farmasi dan kosmetik modern karena keunggulannya dalam biokompatibilitas, spesifisitas target, serta efektivitas pada dosis rendah. Kolagen ikan dan produk degradasinya, yaitu gelatin, merupakan kandidat menjanjikan untuk sumber biomolekul fungsional tersebut. Penelitian ini mengeksplorasi potensi kulit ikan setan merah (Amphilophus labiatus), spesies invasif yang melimpah di Indonesia sebagai sumber alternatif gelatin bernilai tambah. Gelatin diekstraksi dengan metode asam menggunakan 3 variasi konsentrasi asam asetat, yaitu 1, 2, dan 3% (0% sebagai kontrol) dan dikarakterisasi berdasarkan sifat fisikokimia (kekuatan gel dan viskositas) serta profil peptidanya. Perlakuan terbaik diperoleh pada perlakuan menggunakan asam asetat 3% yang menghasilkan rendemen 12,95% dengan kadar protein tinggi (87,2%), kekuatan gel 257,17±17,1 bloom, dan viskositas 6,84±0,87 cP. Analisis lanjutan menggunakan spektrometri massa tandem resolusi tinggi mengidentifikasi 20 jenis kolagen berbeda, dengan kolagen tipe I sebagai yang dominan, serta protein lain dengan domain mirip kolagen seperti kolagen IV NC1 dan fibrillar collagen NC1. Temuan ini menegaskan potensi kulit ikan red devil tidak hanya sebagai strategi pemanfaatan spesies invasif, tetapi juga sebagai sumber biomaterial inovatif untuk aplikasi farmasi dan kosmetik berbasis protein.
- Open Access
- 1 December 2024
- Published by Universitas Gadjah Mada in Indonesian Journal of Chemistry
- Vol. 24 (6) , 1772-1783
Volatilomics Profiling of Counterfeit Perfume by Gas Chromatography Hyphenated to Mass Spectrometry and Fourier-Transformed Infrared Spectroscopy
To prevent deleterious effects on consumers and potential health damage caused by counterfeit perfumes, this study aims to distinguish the original perfume from its suspected counterfeit products. Fingerprint and volatilomics profiling was performed using attenuated total reflection-Fourier infrared spectroscopy (ATR-FTIR) and gas chromatography hyphenated to mass spectrometry (GC-MS). Headspace (HS)-GC-MS was optimized to analyze perfume samples containing water. In the presence of water, our optimized HS-GC-MS method shows linalool's consistent signal intensity, providing an alternative analytical method for water-based perfume formulation. The GC-MS chemical characterization revealed 45 compounds detected in the original sample but only four compounds were detected in the counterfeit products: linalool, citronellol, methyl jasmonate, acetic acid, and propanol. This suggests a clear difference in the formulation of counterfeit products. Counterfeit products also cheat by using a lower amount of ingredients. Relative quantification shows that linalool in counterfeit products was as low as only 5.1% of the amount in the original product. In addition, cheaper and hazardous materials like methanol and 6,7-dihydrogeraniol were detected in counterfeit products. The combination of ATR-FTIR, GC-MS, and HS-GC-MS demonstrated fast authentication of counterfeit perfumes for routine quality control purposes and the possibility of water-based perfume analysis.
- 1 December 2024
- Published by Universitas Gadjah Mada in Indonesian Journal of Chemistry
- Vol. 24 (6) , 1772-1783
Open AccessVolatilomics Profiling of Counterfeit Perfume by Gas Chromatography Hyphenated to Mass Spectrometry and Fourier-Transformed Infrared Spectroscopy
To prevent deleterious effects on consumers and potential health damage caused by counterfeit perfumes, this study aims to distinguish the original perfume from its suspected counterfeit products. Fingerprint and volatilomics profiling was performed using attenuated total reflection-Fourier infrared spectroscopy (ATR-FTIR) and gas chromatography hyphenated to mass spectrometry (GC-MS). Headspace (HS)-GC-MS was optimized to analyze perfume samples containing water. In the presence of water, our optimized HS-GC-MS method shows linalool's consistent signal intensity, providing an alternative analytical method for water-based perfume formulation. The GC-MS chemical characterization revealed 45 compounds detected in the original sample but only four compounds were detected in the counterfeit products: linalool, citronellol, methyl jasmonate, acetic acid, and propanol. This suggests a clear difference in the formulation of counterfeit products. Counterfeit products also cheat by using a lower amount of ingredients. Relative quantification shows that linalool in counterfeit products was as low as only 5.1% of the amount in the original product. In addition, cheaper and hazardous materials like methanol and 6,7-dihydrogeraniol were detected in counterfeit products. The combination of ATR-FTIR, GC-MS, and HS-GC-MS demonstrated fast authentication of counterfeit perfumes for routine quality control purposes and the possibility of water-based perfume analysis.
- 14 April 2023
- Published by Springer Nature in Chemical Papers
- Vol. 77 (8) , 4579-4587
Comprehensive estimation of measurement uncertainty in determination of antioxidant activity in natural product by 2,2ʹ-diphenil-1-picrylhydrazyl (DPPH) radical scavenging assay
- 14 April 2023
- Published by Springer Nature in Chemical Papers
- Vol. 77 (8) , 4579-4587
Comprehensive estimation of measurement uncertainty in determination of antioxidant activity in natural product by 2,2ʹ-diphenil-1-picrylhydrazyl (DPPH) radical scavenging assay
- Open Access
- 15 July 2020
- Published by IntechOpen
Preparing Proteoforms of Therapeutic Proteins for Top-Down Mass Spectrometry
A characteristic of many proteoforms, derived from a single gene, is their similarity regarding the composition of atoms, making their analysis very challenging. Many overexpressed recombinant proteins are strongly associated with this problem, especially recombinant therapeutic glycoproteins from large-scale productions. In contrast to small molecule drugs, which consist of a single defined molecule, therapeutic protein preparations are heterogenous mixtures of dozens or even hundreds of very similar species. With mass spectrometry, currently high-quality spectra of intact proteoforms can be obtained only, if the complexity of the mixture of individual proteoform-ions, entering the gas phase at the same time is low. Thus, prior to mass spectrometric analysis, an effective separation is required for getting fractions with a low number of individual proteoforms. This is especially true not only for recombinant therapeutic proteins, because of their huge heterogeneity, but also relevant for top-down proteomics. Purification of proteoforms is the bottleneck in analyzing intact proteoforms with mass spectrometry. This review is focusing on the current state of the art, especially of liquid chromatography for preparing proteoforms for mass spectrometric top-down analysis. The topic of therapeutic proteins has been chosen, because this group of proteins is most challenging regarding their proteoform analysis.
- 15 July 2020
- Published by IntechOpen
Open AccessPreparing Proteoforms of Therapeutic Proteins for Top-Down Mass Spectrometry
A characteristic of many proteoforms, derived from a single gene, is their similarity regarding the composition of atoms, making their analysis very challenging. Many overexpressed recombinant proteins are strongly associated with this problem, especially recombinant therapeutic glycoproteins from large-scale productions. In contrast to small molecule drugs, which consist of a single defined molecule, therapeutic protein preparations are heterogenous mixtures of dozens or even hundreds of very similar species. With mass spectrometry, currently high-quality spectra of intact proteoforms can be obtained only, if the complexity of the mixture of individual proteoform-ions, entering the gas phase at the same time is low. Thus, prior to mass spectrometric analysis, an effective separation is required for getting fractions with a low number of individual proteoforms. This is especially true not only for recombinant therapeutic proteins, because of their huge heterogeneity, but also relevant for top-down proteomics. Purification of proteoforms is the bottleneck in analyzing intact proteoforms with mass spectrometry. This review is focusing on the current state of the art, especially of liquid chromatography for preparing proteoforms for mass spectrometric top-down analysis. The topic of therapeutic proteins has been chosen, because this group of proteins is most challenging regarding their proteoform analysis.
- Open Access
- 1 February 2020
- Published by Elsevier in Cell Systems
- Vol. 10 (2) , 213-218.e6
FLASHDeconv: Ultrafast, High-Quality Feature Deconvolution for Top-Down Proteomics
- 1 February 2020
- Published by Elsevier in Cell Systems
- Vol. 10 (2) , 213-218.e6
Open AccessFLASHDeconv: Ultrafast, High-Quality Feature Deconvolution for Top-Down Proteomics
- Open Access
- 17 January 2019
- Published by MDPI AG in Pharmaceuticals
- Vol. 12 (1) , 14
Structural and In Vitro Functional Comparability Analysis of Altebrel™, a Proposed Etanercept Biosimilar: Focus on Primary Sequence and Glycosylation
The demand for reliable comparability studies of biosimilars grows with their increased market share. These studies focus on physicochemical, structural, functional and clinical properties to ensure that a biosimilar has no significant differences to the originator product and can be released into the market without extensive clinical trials. In the current study, Enbrel® (etanercept, the originator) and Altebrel™ (the proposed biosimilar) underwent direct comparison. “Bottom-up” mass spectrometric analysis was used for primary sequence analysis, evaluation of N/O-glycosylation sites and quantification of methionine oxidation. N/O-glycans were analyzed after permethylation derivatization and the effect of N-glycans on in-vitro functionality of etanercept was assayed. Three enzyme peptide mapping resulted in complete identification of the primary structure. It was confirmed that total ion chromatograms are valuable datasets for the analysis of the primary structure of biodrugs. New N/O-glycan structures were identified and all the N-glycans were quantified. Finally, investigation of the functional properties of N-deglycosylated and non-modified etanercept samples using surface plasmon resonance analysis and in-vitro bioassay showed that N-glycosylation has no significant effect on its in-vitro functionality. Analysis of etanercept and its biosimilar, revealed a high similarity in terms of glycosylation, primary structure and in-vitro functionality.
- 17 January 2019
- Published by MDPI AG in Pharmaceuticals
- Vol. 12 (1) , 14
Open AccessStructural and In Vitro Functional Comparability Analysis of Altebrel™, a Proposed Etanercept Biosimilar: Focus on Primary Sequence and Glycosylation
The demand for reliable comparability studies of biosimilars grows with their increased market share. These studies focus on physicochemical, structural, functional and clinical properties to ensure that a biosimilar has no significant differences to the originator product and can be released into the market without extensive clinical trials. In the current study, Enbrel® (etanercept, the originator) and Altebrel™ (the proposed biosimilar) underwent direct comparison. “Bottom-up” mass spectrometric analysis was used for primary sequence analysis, evaluation of N/O-glycosylation sites and quantification of methionine oxidation. N/O-glycans were analyzed after permethylation derivatization and the effect of N-glycans on in-vitro functionality of etanercept was assayed. Three enzyme peptide mapping resulted in complete identification of the primary structure. It was confirmed that total ion chromatograms are valuable datasets for the analysis of the primary structure of biodrugs. New N/O-glycan structures were identified and all the N-glycans were quantified. Finally, investigation of the functional properties of N-deglycosylated and non-modified etanercept samples using surface plasmon resonance analysis and in-vitro bioassay showed that N-glycosylation has no significant effect on its in-vitro functionality. Analysis of etanercept and its biosimilar, revealed a high similarity in terms of glycosylation, primary structure and in-vitro functionality.
- Open Access
- 16 November 2018
- Published by MDPI AG in Preprints.org
Structural and In Vitro Functional Comparability Analysis of Altebrel™, a Proposed Etanercept Biosimilar: Focus on Primary Sequence and Glycosylation
Background: The demand for reliable comparability studies of biosimilars grows with the increase of their market. These studies focus on physicochemical, structural, functional and clinical properties to ensure that a biosimilar has no significant differences to the originator product and can be released into the market without extensive clinical trials. Methods: In the current study, Enbrel® (the originator) and Altebrel™ (the proposed biosimilar) underwent direct comparison. “Bottom-up” mass spectrometric analysis was used for primary sequence analysis, evaluation of N/O-glycosylation sites and quantification of methionine oxidation. N/O-glycans were analyzed after permethylation derivatization and the effect of N-glycans on in-vitro functionality of etanercept was assayed. Results: Three enzyme peptide mapping resulted in an identification of the primary sequence completely. It was stated that total ion chromatograms should be considered as a highly valuable data for analyzing the biodrug primary sequence and variations. New N/O-glycan structures were identified and all the N-glycans were quantified. Finally, functional properties of N-deglycosylated and non-modified etanercept samples were investigated using surface plasmon resonance analysis and in-vitro bioassay. Conclusion: It was shown that N-glycosylation has no significant effect on in-vitro functionality of etanercept. Moreover, comparison of etanercept samples stated the high similarity between the originator and the proposed biosimilar.
- 16 November 2018
- Published by MDPI AG in Preprints.org
Open AccessStructural and In Vitro Functional Comparability Analysis of Altebrel™, a Proposed Etanercept Biosimilar: Focus on Primary Sequence and Glycosylation
Background: The demand for reliable comparability studies of biosimilars grows with the increase of their market. These studies focus on physicochemical, structural, functional and clinical properties to ensure that a biosimilar has no significant differences to the originator product and can be released into the market without extensive clinical trials. Methods: In the current study, Enbrel® (the originator) and Altebrel™ (the proposed biosimilar) underwent direct comparison. “Bottom-up” mass spectrometric analysis was used for primary sequence analysis, evaluation of N/O-glycosylation sites and quantification of methionine oxidation. N/O-glycans were analyzed after permethylation derivatization and the effect of N-glycans on in-vitro functionality of etanercept was assayed. Results: Three enzyme peptide mapping resulted in an identification of the primary sequence completely. It was stated that total ion chromatograms should be considered as a highly valuable data for analyzing the biodrug primary sequence and variations. New N/O-glycan structures were identified and all the N-glycans were quantified. Finally, functional properties of N-deglycosylated and non-modified etanercept samples were investigated using surface plasmon resonance analysis and in-vitro bioassay. Conclusion: It was shown that N-glycosylation has no significant effect on in-vitro functionality of etanercept. Moreover, comparison of etanercept samples stated the high similarity between the originator and the proposed biosimilar.